稳中向好趋势延续,机构建议今年创新药BD关注这些领域

制药网
Feb 09

近年来,随着国内创新药的不断发展,国产创新药不断走出去,2025年我国创新药BD出海项目数量、总金额等均显著增加,有业内预测,未来3-5年,仍是中国BD的大年。另有机构建议,在2026年医药业务拓展(BD)中,关注小核酸、长效制剂、invivo CAR-T、新一代ADC/XDC等差异化平台,以及自免、代谢、CNS等疾病领域,其认为该板块稳中向好的趋势将于今年延续,但仍有可能出现短期波动。如在小核酸...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10